Twelve-Week Treatment With Liraglutide as Add-on to Insulin in Normal-Weight Patients With Poorly Controlled Type 1 Diabetes: A Randomized, Placebo-Controlled, Double-Blind Parallel Study.
Twelve-week treatment with glucurin as an add-on to insulin in normal-weight patients with poorly controlled Type 1 diabetes: a randomized, placebo-controlled, double-blind parallel study.